Allmed Solutions Ltd (ALMD) Fair Value & Analysis
Healthcare · Il · Market cap 32.6M ILA · ISIN IL0011014508
Risks
Fair value as of: Aug 13, 2026
From 2 valuation models · updated 14 days ago
Fair value updated Aug 13, 2026, revised from 0.1300 ILA to 0.1100 ILA (−15.4%) since Jul 14, 2026. Share price −0.7% over the past month.
A solid business, but trading 168% above our fair value.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case (0.1400 ILA). The favourable scenario is already priced in.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- Solid but not exceptional quality (65/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 0.2490 ILA – 0.9290 ILA · fair‑value band 0.0900 ILA – 0.1400 ILA · the 0.2950 ILA price screens above the 0.1100 ILA fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Allmed Solutions Ltd (ALMD) currently trades at 0.2950 ILA, while our model-based Fair Value estimate is 0.1100 ILA, implying the stock looks roughly 62.7% overvalued today. The Quality Score stands at 65/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at 283K ILA. It earns a return on equity of -40.3%. The balance sheet holds a net cash position of 3.3M ILA. Fundamentals as of Aug 13, 2026
Our scenario range runs from 0.0900 ILA (bear case) to 0.1400 ILA (bull case); at 0.2950 ILA, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Healthcare peers we cover trades at -34% fair-value upside, at -63%, ALMD screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 2 models by family
Widest divergence: Asset-Based (0.1800 ILA) versus DCF Models (0.0900 ILA). Highest evidence: NCAV (Graham) (50).
Notify me when ALMD reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 66 · Market factors (momentum, volatility) 36
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally.
Full company description
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It is also involved in the development of a mitral valve regurgitation solution. The company was formerly known as Allium Medical Solutions Ltd. Allmed Solutions Ltd was incorporated in 2004 and is based in Or Akiva, Israel.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Allmed Solutions Ltd reported revenue of 0 ILS in FY2025 versus 5.5M ILS in FY2021. Reported net income was −14.1K ILS in FY2025.
ALMD screens 63% overvalued. Compare with Abbott Laboratories, →
Peer Group
Medical Devices · 363 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Devices median · lower = cheaper
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | $114.10 | $74.79 | -34% |
| Stryker Corporation SYK | $329.67 | $186.28 | -43% |
| Medtronic plc MDT | $92.02 | $65.57 | -29% |
| Boston Scientific Corporation BSX | $48.17 | $30.73 | -36% |
| Edwards Lifesciences Corporation EW | $90.78 | $41.02 | -55% |
| Siemens Healthineers AG SHL | €39.26 | €33.87 | -14% |
| DexCom, Inc DXCM | $88.96 | $38.95 | -56% |
| GE HealthCare Technologies Inc GEHC | $74.82 | $64.13 | -14% |
| Koninklijke Philips N.V PHIA | €23.69 | €14.36 | -39% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥150.63 | ¥147.63 | -2% |
Compare Allmed Solutions Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Allmed Solutions Ltd (ALMD) overvalued or undervalued?
What is the fair value of ALMD?
What is the quality score of ALMD?
What is the revenue of Allmed Solutions Ltd (ALMD)?
What is the net profit margin of ALMD?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Watch Allmed Solutions Ltd in the live analysis
One click puts Allmed Solutions Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.